KEMADRIN IN THE TREATMENT OF PARKINSONISM: A DOUBLE BLIND AND ONE-YEAR FOLLOW-UP STUDY.
D035843:Biomedical Research; D004311:Double-Blind Method; D004358:Drug Therapy; D005500:Follow-Up Studies; D010276:Parasympatholytics; D020734:Parkinsonian Disorders; D011352:Procyclidine
D010276:Parasympatholytics; D011352:Procyclidine
CLINICAL RESEARCH; DRUG THERAPY; PARASYMPATHOLYTICS; PARKINSONISM